These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28786797)

  • 1. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Jensenius M; Winje BA; Blomberg B; Mengshoel AT; Lippe Bv; Hannula R; Bruun JN; Knudsen PK; Rønning JO; Heldal E; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):786-92. PubMed ID: 27155182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
    Umanah TA; Ncayiyana JR; Nyasulu PS
    Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Htet KKK; Soe KT; Kumar AMV; Saw S; Win Maung HM; Myint Z; Khine TMM; Aung ST
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):385-392. PubMed ID: 29562985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia.
    Mutembo S; Mutanga JN; Musokotwane K; Kanene C; Dobbin K; Yao X; Li C; Marconi VC; Whalen CC
    BMC Infect Dis; 2019 Dec; 19(1):1087. PubMed ID: 31888518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active contact tracing beyond the household in multidrug resistant tuberculosis in Vietnam: a cohort study.
    Hoang TTT; Nguyen VN; Dinh NS; Thwaites G; Nguyen TA; van Doorn HR; Cobelens F; Wertheim HFL
    BMC Public Health; 2019 Feb; 19(1):241. PubMed ID: 30819161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    van Altena R; de Vries G; Haar CH; de Lange WC; Magis-Escurra C; van den Hof S; van Soolingen D; Boeree MJ; van der Werf TS
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):406-12. PubMed ID: 25859995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
    Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries.
    Ballif M; Christ B; Anderegg N; Chammartin F; Muhairwe J; Jefferys L; Hector J; van Dijk J; Vinikoor MJ; van Lettow M; Chimbetete C; Phiri SJ; Onoya D; Fox MP; Egger M
    Clin Infect Dis; 2022 Jan; 74(2):171-179. PubMed ID: 33993219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Moore BK; Anyalechi E; van der Walt M; Smith S; Erasmus L; Lancaster J; Morris S; Ndjeka N; Ershova J; Ismail N; Burton D; Menzies H
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):663-9. PubMed ID: 25946356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Nanzaluka FH; Chibuye S; Kasapo CC; Langa N; Nyimbili S; Moonga G; Kapata N; Kumar R; Chongwe G
    Pan Afr Med J; 2019; 32():159. PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of drug-resistant tuberculosis when first-line therapy fails in a high HIV prevalence setting.
    Satti H; McLaughlin MM; Seung KJ; Becerra MC; Keshavjee S
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):100-6. PubMed ID: 23232009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and outcomes of an active defaulter tracing system for HIV, prevention of mother to child transmission of HIV (PMTCT), and TB patients in Kibera, Nairobi, Kenya.
    Thomson KA; Cheti EO; Reid T
    Trans R Soc Trop Med Hyg; 2011 Jun; 105(6):320-6. PubMed ID: 21511317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.
    Weigel R; Hochgesang M; Brinkhof MW; Hosseinipour MC; Boxshall M; Mhango E; Nkwazi B; Tweya H; Kamlaka M; Chagwera F; Phiri S
    BMC Infect Dis; 2011 Jan; 11():31. PubMed ID: 21272350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.